- More Data Suggests New Coronavirus Variants Weaken Vaccines, Treatments
- Moderna COVID Vaccine Can Sometimes Trigger Delayed Skin Reactions
- Perils of the Pandemic: Scooters, Cleansers and Button Batteries
- American Indians Face the Highest Odds for Stroke
- COVID Leaves Most Pro Athletes With No Lasting Heart Damage: Study
- AHA News: Bypass Surgery Turned Doctor From Couch Potato Into Mountain Climber
- U.S. Hispanics at High Heart Disease Risk and Many Go Untreated: Report
- Catnip Might Be Your Next Mosquito Repellent
- COVID Death Rates 10 Times Higher in Countries Where Most Are Overweight: Report
- Health Highlights: March 4, 2021
Benicar Approved for Kids With High Blood Pressure
THURSDAY, Feb. 11Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16, drug maker Daiichi Sankyo said Thursday.
Some 3.6 million children in the United States have high blood pressure, a number that’s risen in tandem with children’s weight, the company said in a news release. Obese children are three times more likely to have hypertension than non-obese kids, the firm added.
Benicar blocks the actions of a hormone called angiotensin II to increase blood pressure.
Adverse reactions reported among children taking Benicar were similar to those of adults, including dizziness, Daiichi said.
More information
To learn more about high blood pressure in children, visit the American Heart Association.
Source: HealthDay
